Livio Gargantini

1.6k total citations
31 papers, 1.1k citations indexed

About

Livio Gargantini is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Livio Gargantini has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 12 papers in Genetics and 12 papers in Oncology. Recurrent topics in Livio Gargantini's work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (8 papers). Livio Gargantini is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (8 papers). Livio Gargantini collaborates with scholars based in Italy, United States and Switzerland. Livio Gargantini's co-authors include Enrica Morra, Catherine Klersy, Mario Lazzarino, Ester Pungolino, Luciana Barbarano, Ercole Brusamolino, Clara Cesana, Monica Crugnola, Anna Maria Nosari and Carlo Bernasconi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Livio Gargantini

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Livio Gargantini Italy 19 563 396 311 286 193 31 1.1k
Surender Juneja Australia 20 541 1.0× 375 0.9× 538 1.7× 489 1.7× 121 0.6× 85 1.3k
J R Anderson United States 13 881 1.6× 603 1.5× 261 0.8× 181 0.6× 170 0.9× 21 1.3k
Oumédaly Reman France 20 362 0.6× 385 1.0× 236 0.8× 635 2.2× 149 0.8× 61 1.4k
Gavin Cull Australia 17 662 1.2× 367 0.9× 601 1.9× 332 1.2× 230 1.2× 67 1.2k
Hirofumi Taji Japan 19 654 1.2× 603 1.5× 169 0.5× 110 0.4× 200 1.0× 35 1.2k
W S Velasquez United States 16 845 1.5× 670 1.7× 367 1.2× 203 0.7× 238 1.2× 17 1.3k
S Pavlovsky Argentina 21 569 1.0× 585 1.5× 265 0.9× 408 1.4× 236 1.2× 81 1.4k
D.P. Deakin United Kingdom 21 755 1.3× 449 1.1× 284 0.9× 150 0.5× 236 1.2× 40 1.2k
Takafumi Matsushima Japan 17 266 0.5× 200 0.5× 263 0.8× 417 1.5× 79 0.4× 57 933
Maurizio Musso Italy 19 334 0.6× 364 0.9× 243 0.8× 702 2.5× 110 0.6× 68 1.4k

Countries citing papers authored by Livio Gargantini

Since Specialization
Citations

This map shows the geographic impact of Livio Gargantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Livio Gargantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Livio Gargantini more than expected).

Fields of papers citing papers by Livio Gargantini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Livio Gargantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Livio Gargantini. The network helps show where Livio Gargantini may publish in the future.

Co-authorship network of co-authors of Livio Gargantini

This figure shows the co-authorship network connecting the top 25 collaborators of Livio Gargantini. A scholar is included among the top collaborators of Livio Gargantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Livio Gargantini. Livio Gargantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ceriani, Luca, Maurizio Martelli, Pier Luigi Zinzani, et al.. (2015). Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood. 126(8). 950–956. 134 indexed citations
2.
Russo, L., Dario Iafusco, Sonia Brescianini, et al.. (2011). Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia. 54(7). 1693–1701. 55 indexed citations
3.
Arcaini, Luca, Francesca Montanari, Emilio Paolo Alessandrino, et al.. (2008). Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma. Annals of Oncology. 19(7). 1331–1335. 25 indexed citations
4.
Berto, Patrizia, Stefania Lopatriello, Luca Arcaini, et al.. (2007). Costo-efficacia di rituximab nella terapia di mantenimento in soggetti affetti da linfoma non-Hodgkin follicolare refrattario. IRIS Research product catalog (Sapienza University of Rome). 9(1). 9–19. 1 indexed citations
5.
Pungolino, Ester, Silvia Cantoni, Livio Gargantini, et al.. (2007). Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.. Blood. 110(11). 4577–4577. 1 indexed citations
6.
Brusamolino, Ercole, Chiara Rusconi, Livio Gargantini, et al.. (2006). Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.. PubMed. 91(4). 496–502. 83 indexed citations
7.
Nosari, A., Roberto Cairoli, Livio Gargantini, et al.. (2006). Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens. Bone Marrow Transplantation. 38(6). 413–416. 20 indexed citations
8.
Gallamini, Andrea, Francesco Zaja, Livio Gargantini, et al.. (2005). CHOP Chemotherapy Plus Campath-1H (CHOP-C) as First Line Treatment in Patients with Peripheral T-Cell Lymphoma (PTCL).. Blood. 106(11). 3345–3345. 7 indexed citations
9.
Muti, Giuliana, Catherine Klersy, Fausto Baldanti, et al.. (2003). Epstein–Barr virus (EBV) load and interleukin‐10 in EBV‐positive and EBV‐negative post‐transplant lymphoproliferative disorders. British Journal of Haematology. 122(6). 927–933. 32 indexed citations
11.
Silini, Enrico Maria, Anna Locasciulli, Luca Santoleri, et al.. (2002). Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome.. PubMed. 87(11). 1200–8. 35 indexed citations
12.
Pioltelli, Pietro, et al.. (2000). Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. American Journal of Hematology. 64(2). 95–100. 51 indexed citations
13.
Perego, R, Melania Costantini, Livio Gargantini, et al.. (2000). The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia. European Journal of Cancer. 36(11). 1395–1401. 52 indexed citations
14.
Morra, Enrica, Livio Gargantini, Annamaria Nosari, et al.. (2000). Treatment of patients with high-grade non-Hodgkin’s lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators. Critical Reviews in Oncology/Hematology. 35(2). 95–100. 2 indexed citations
15.
Gargantini, Livio, Luciano Beccaria, L. Bosio, et al.. (1999). La sindrome di Prader-Willi: Un problema pediatrico. 25(6). 1050–1055. 2 indexed citations
16.
Nosari, A., Andrea Biondi, Luca Santoleri, et al.. (1999). Hepato-splenic ?? T-cell lymphoma: A rare entity mimicking the hemophagocytic syndrome. American Journal of Hematology. 60(1). 61–65. 36 indexed citations
17.
Lazzarino, Mario, Ester Orlandi, Catherine Klersy, et al.. (1998). Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.. PubMed. 82(3). 576–82. 42 indexed citations
18.
Lazzarino, Mario, Ester Orlandi, Marco Paulli, et al.. (1997). Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.. Journal of Clinical Oncology. 15(4). 1646–1653. 114 indexed citations
19.
Nosari, Annamaria, Silvia Cantoni, Pierluigi Oreste, et al.. (1996). Anaplastic large cell (CD30/Ki‐1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients. British Journal of Haematology. 95(3). 508–512. 23 indexed citations
20.
Landonio, Giuseppe, et al.. (1990). Pulmonary and myocardial infarction secondary to arterial occlusion by Aspergillus fumigatus in ANLL.. PubMed. 74(5). 503–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026